{'fraction_non_alphanumeric': 0.02865329512893983, 'fraction_numerical': 0.022922636103151862, 'mean_word_length': 4.46875, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Thalidomide for diarrhea.


 A phase II trial is beginning using thalidomide as a treatment for chronic diarrhea in HIV-infected patients. The 28-day trial will randomize 120 patients to placebo or 100 mg thalidomide daily. Areas monitored will include changes in body weight, quality of life, and tumor necrosis factor (TNF) in small bowel tissue.
